Another study reported BRCA1/2 mutations in 25% of high-risk breast cancer patients with NMSC, with BRCA1 being more prevalent, but the small sample size of only 16 cases limits its significance [86]. The gene discussed is BRCA1; the disease is breast carcinoma.